[1]
Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiology and immunology. 2009 Jan:53(1):41-4. doi: 10.1111/j.1348-0421.2008.00083.x. Epub
[PubMed PMID: 19161556]
[2]
Sabino R, Veríssimo C, Pereira ÁA, Antunes F. Candida auris, an Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind? Microorganisms. 2020 Jan 28:8(2):. doi: 10.3390/microorganisms8020181. Epub 2020 Jan 28
[PubMed PMID: 32012865]
[3]
Deorukhkar SC, Saini S, Mathew S. Non-albicans Candida Infection: An Emerging Threat. Interdisciplinary perspectives on infectious diseases. 2014:2014():615958. doi: 10.1155/2014/615958. Epub 2014 Oct 22
[PubMed PMID: 25404942]
Level 3 (low-level) evidence
[4]
Muñoz JF, Gade L, Chow NA, Loparev VN, Juieng P, Berkow EL, Farrer RA, Litvintseva AP, Cuomo CA. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species. Nature communications. 2018 Dec 17:9(1):5346. doi: 10.1038/s41467-018-07779-6. Epub 2018 Dec 17
[PubMed PMID: 30559369]
[5]
Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, Jain S, Kathuria S, Randhawa HS, Hagen F, Meis JF. New clonal strain of Candida auris, Delhi, India. Emerging infectious diseases. 2013 Oct:19(10):1670-3. doi: 10.3201/eid1910.130393. Epub
[PubMed PMID: 24048006]
[6]
Wang X, Bing J, Zheng Q, Zhang F, Liu J, Yue H, Tao L, Du H, Wang Y, Wang H, Huang G. The first isolate of Candida auris in China: clinical and biological aspects. Emerging microbes & infections. 2018 May 18:7(1):93. doi: 10.1038/s41426-018-0095-0. Epub 2018 May 18
[PubMed PMID: 29777096]
[7]
Kim SH, Iyer KR, Pardeshi L, Muñoz JF, Robbins N, Cuomo CA, Wong KH, Cowen LE. Genetic Analysis of Candida auris Implicates Hsp90 in Morphogenesis and Azole Tolerance and Cdr1 in Azole Resistance. mBio. 2019 Jan 29:10(1):. doi: 10.1128/mBio.02529-18. Epub 2019 Jan 29
[PubMed PMID: 30696744]
[8]
Cortegiani A, Misseri G, Fasciana T, Giammanco A, Giarratano A, Chowdhary A. Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. Journal of intensive care. 2018:6():69. doi: 10.1186/s40560-018-0342-4. Epub 2018 Oct 29
[PubMed PMID: 30397481]
[9]
Chow NA, de Groot T, Badali H, Abastabar M, Chiller TM, Meis JF. Potential Fifth Clade of Candida auris, Iran, 2018. Emerging infectious diseases. 2019 Sep:25(9):1780-1781. doi: 10.3201/eid2509.190686. Epub 2019 Sep 17
[PubMed PMID: 31310230]
[10]
Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS. Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris. Journal of clinical microbiology. 2017 Aug:55(8):2445-2452. doi: 10.1128/JCM.00630-17. Epub 2017 May 24
[PubMed PMID: 28539346]
[11]
Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017 Jan 15:64(2):134-140. doi: 10.1093/cid/ciw691. Epub 2016 Oct 20
[PubMed PMID: 27988485]
Level 2 (mid-level) evidence
[12]
Lee WG, Shin JH, Uh Y, Kang MG, Kim SH, Park KH, Jang HC. First three reported cases of nosocomial fungemia caused by Candida auris. Journal of clinical microbiology. 2011 Sep:49(9):3139-42. doi: 10.1128/JCM.00319-11. Epub 2011 Jun 29
[PubMed PMID: 21715586]
Level 3 (low-level) evidence
[13]
Lone SA, Ahmad A. Candida auris-the growing menace to global health. Mycoses. 2019 Aug:62(8):620-637. doi: 10.1111/myc.12904. Epub 2019 Jun 18
[PubMed PMID: 30773703]
[14]
Ben-Ami R, Berman J, Novikov A, Bash E, Shachor-Meyouhas Y, Zakin S, Maor Y, Tarabia J, Schechner V, Adler A, Finn T. Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerging infectious diseases. 2017 Feb:23(1):195-203. doi: 10.3201/eid2302.161486. Epub
[PubMed PMID: 28098529]
[15]
Ruiz Gaitán AC, Moret A, López Hontangas JL, Molina JM, Aleixandre López AI, Cabezas AH, Mollar Maseres J, Arcas RC, Gómez Ruiz MD, Chiveli MÁ, Cantón E, Pemán J. Nosocomial fungemia by Candida auris: First four reported cases in continental Europe. Revista iberoamericana de micologia. 2017 Jan-Mar:34(1):23-27. doi: 10.1016/j.riam.2016.11.002. Epub 2017 Jan 25
[PubMed PMID: 28131716]
Level 3 (low-level) evidence
[16]
Al-Siyabi T, Al Busaidi I, Balkhair A, Al-Muharrmi Z, Al-Salti M, Al'Adawi B. First report of Candida auris in Oman: Clinical and microbiological description of five candidemia cases. The Journal of infection. 2017 Oct:75(4):373-376. doi: 10.1016/j.jinf.2017.05.016. Epub 2017 Jun 1
[PubMed PMID: 28579303]
Level 3 (low-level) evidence
[17]
Schwartz IS, Hammond GW. First reported case of multidrug-resistant Candida auris in Canada. Canada communicable disease report = Releve des maladies transmissibles au Canada. 2017 Jul 6:43(7-8):150-153
[PubMed PMID: 29770082]
Level 3 (low-level) evidence
[18]
Tsay S, Welsh RM, Adams EH, Chow NA, Gade L, Berkow EL, Poirot E, Lutterloh E, Quinn M, Chaturvedi S, Kerins J, Black SR, Kemble SK, Barrett PM, MSD, Barton K, Shannon DJ, Bradley K, Lockhart SR, Litvintseva AP, Moulton-Meissner H, Shugart A, Kallen A, Vallabhaneni S, Chiller TM, Jackson BR. Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities - United States, June 2016-May 2017. MMWR. Morbidity and mortality weekly report. 2017 May 19:66(19):514-515. doi: 10.15585/mmwr.mm6619a7. Epub 2017 May 19
[PubMed PMID: 28520710]
[19]
Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, Kemble SK, Pacilli M, Black SR, Landon E, Ridgway J, Palmore TN, Zelzany A, Adams EH, Quinn M, Chaturvedi S, Greenko J, Fernandez R, Southwick K, Furuya EY, Calfee DP, Hamula C, Patel G, Barrett P, Lafaro P, Berkow EL, Moulton-Meissner H, Noble-Wang J, Fagan RP, Jackson BR, Lockhart SR, Litvintseva AP, Chiller TM. Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus-United States, May 2013-August 2016. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2017 Jan:17(1):296-299. doi: 10.1111/ajt.14121. Epub
[PubMed PMID: 28029734]
Level 3 (low-level) evidence
[20]
Spivak ES, Hanson KE. Candida auris: an Emerging Fungal Pathogen. Journal of clinical microbiology. 2018 Feb:56(2):. doi: 10.1128/JCM.01588-17. Epub 2018 Jan 24
[PubMed PMID: 29167291]
[21]
Day AM, McNiff MM, da Silva Dantas A, Gow NAR, Quinn J. Hog1 Regulates Stress Tolerance and Virulence in the Emerging Fungal Pathogen Candida auris. mSphere. 2018 Oct 24:3(5):. doi: 10.1128/mSphere.00506-18. Epub 2018 Oct 24
[PubMed PMID: 30355673]
[22]
Forsberg K, Woodworth K, Walters M, Berkow EL, Jackson B, Chiller T, Vallabhaneni S. Candida auris: The recent emergence of a multidrug-resistant fungal pathogen. Medical mycology. 2019 Jan 1:57(1):1-12. doi: 10.1093/mmy/myy054. Epub
[PubMed PMID: 30085270]
[23]
Biswal M, Rudramurthy SM, Jain N, Shamanth AS, Sharma D, Jain K, Yaddanapudi LN, Chakrabarti A. Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions. The Journal of hospital infection. 2017 Dec:97(4):363-370. doi: 10.1016/j.jhin.2017.09.009. Epub 2017 Sep 19
[PubMed PMID: 28939316]
[24]
Cortegiani A, Misseri G, Giarratano A, Bassetti M, Eyre D. The global challenge of Candida auris in the intensive care unit. Critical care (London, England). 2019 May 2:23(1):150. doi: 10.1186/s13054-019-2449-y. Epub 2019 May 2
[PubMed PMID: 31046836]
[25]
Piedrahita CT, Cadnum JL, Jencson AL, Shaikh AA, Ghannoum MA, Donskey CJ. Environmental Surfaces in Healthcare Facilities are a Potential Source for Transmission of Candida auris and Other Candida Species. Infection control and hospital epidemiology. 2017 Sep:38(9):1107-1109. doi: 10.1017/ice.2017.127. Epub 2017 Jul 11
[PubMed PMID: 28693657]
[26]
Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, Litvintseva AP. Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface. Journal of clinical microbiology. 2017 Oct:55(10):2996-3005. doi: 10.1128/JCM.00921-17. Epub 2017 Jul 26
[PubMed PMID: 28747370]
[27]
Chowdhary A, Sharma C, Meis JF. Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS pathogens. 2017 May:13(5):e1006290. doi: 10.1371/journal.ppat.1006290. Epub 2017 May 18
[PubMed PMID: 28542486]
[28]
Sharma C, Kumar N, Pandey R, Meis JF, Chowdhary A. Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation. New microbes and new infections. 2016 Sep:13():77-82. doi: 10.1016/j.nmni.2016.07.003. Epub 2016 Jul 29
[PubMed PMID: 27617098]
[29]
Chatterjee S, Alampalli SV, Nageshan RK, Chettiar ST, Joshi S, Tatu US. Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris. BMC genomics. 2015 Sep 7:16(1):686. doi: 10.1186/s12864-015-1863-z. Epub 2015 Sep 7
[PubMed PMID: 26346253]
[30]
Larkin E, Hager C, Chandra J, Mukherjee PK, Retuerto M, Salem I, Long L, Isham N, Kovanda L, Borroto-Esoda K, Wring S, Angulo D, Ghannoum M. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. Antimicrobial agents and chemotherapy. 2017 May:61(5):. doi: 10.1128/AAC.02396-16. Epub 2017 Apr 24
[PubMed PMID: 28223375]
[31]
Johnson CJ, Davis JM, Huttenlocher A, Kernien JF, Nett JE. Emerging Fungal Pathogen Candida auris Evades Neutrophil Attack. mBio. 2018 Aug 21:9(4):. doi: 10.1128/mBio.01403-18. Epub 2018 Aug 21
[PubMed PMID: 30131360]
[32]
Navarro-Arias MJ, Hernández-Chávez MJ, García-Carnero LC, Amezcua-Hernández DG, Lozoya-Pérez NE, Estrada-Mata E, Martínez-Duncker I, Franco B, Mora-Montes HM. Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells. Infection and drug resistance. 2019:12():783-794. doi: 10.2147/IDR.S197531. Epub 2019 Apr 8
[PubMed PMID: 31040708]
[33]
Sherry L, Ramage G, Kean R, Borman A, Johnson EM, Richardson MD, Rautemaa-Richardson R. Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris. Emerging infectious diseases. 2017 Feb:23(2):328-331. doi: 10.3201/eid2302.161320. Epub
[PubMed PMID: 28098553]
[34]
Borman AM, Szekely A, Johnson EM. Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species. mSphere. 2016 Jul-Aug:1(4):. doi: 10.1128/mSphere.00189-16. Epub 2016 Aug 18
[PubMed PMID: 27547827]
Level 2 (mid-level) evidence
[35]
Mitchell KF, Zarnowski R, Sanchez H, Edward JA, Reinicke EL, Nett JE, Mitchell AP, Andes DR. Community participation in biofilm matrix assembly and function. Proceedings of the National Academy of Sciences of the United States of America. 2015 Mar 31:112(13):4092-7. doi: 10.1073/pnas.1421437112. Epub 2015 Mar 13
[PubMed PMID: 25770218]
[36]
Dominguez EG, Zarnowski R, Choy HL, Zhao M, Sanchez H, Nett JE, Andes DR. Conserved Role for Biofilm Matrix Polysaccharides in Candida auris Drug Resistance. mSphere. 2019 Jan 2:4(1):. doi: 10.1128/mSphereDirect.00680-18. Epub 2019 Jan 2
[PubMed PMID: 30602527]
[37]
Romera D, Aguilera-Correa JJ, Gadea I, Viñuela-Sandoval L, García-Rodríguez J, Esteban J. Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs. Journal of medical microbiology. 2019 Sep:68(9):1353-1358. doi: 10.1099/jmm.0.001036. Epub 2019 Jul 4
[PubMed PMID: 31271350]
[38]
Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, Tarai B, Singh A, Upadhyaya G, Upadhyay S, Yadav P, Singh PK, Khillan V, Sachdeva N, Perlin DS, Meis JF. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. The Journal of antimicrobial chemotherapy. 2018 Apr 1:73(4):891-899. doi: 10.1093/jac/dkx480. Epub
[PubMed PMID: 29325167]
[39]
Kean R, McKloud E, Townsend EM, Sherry L, Delaney C, Jones BL, Williams C, Ramage G. The comparative efficacy of antiseptics against Candida auris biofilms. International journal of antimicrobial agents. 2018 Nov:52(5):673-677. doi: 10.1016/j.ijantimicag.2018.05.007. Epub 2018 Oct 8
[PubMed PMID: 29775686]
Level 2 (mid-level) evidence
[40]
Sarma S, Upadhyay S. Current perspective on emergence, diagnosis and drug resistance in Candida auris. Infection and drug resistance. 2017:10():155-165. doi: 10.2147/IDR.S116229. Epub 2017 Jun 7
[PubMed PMID: 28652784]
Level 3 (low-level) evidence
[41]
Choi HI, An J, Hwang JJ, Moon SY, Son JS. Otomastoiditis caused by Candida auris: Case report and literature review. Mycoses. 2017 Aug:60(8):488-492. doi: 10.1111/myc.12617. Epub 2017 Apr 5
[PubMed PMID: 28378904]
Level 3 (low-level) evidence
[42]
Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, Lee JS, Jung SI, Park KH, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009 Mar 15:48(6):e57-61. doi: 10.1086/597108. Epub
[PubMed PMID: 19193113]
[43]
Emara M, Ahmad S, Khan Z, Joseph L, Al-Obaid I, Purohit P, Bafna R. Candida auris candidemia in Kuwait, 2014. Emerging infectious diseases. 2015 Jun:21(6):1091-2. doi: 10.3201/eid2106.150270. Epub
[PubMed PMID: 25989098]
[44]
Magobo RE, Corcoran C, Seetharam S, Govender NP. Candida auris-associated candidemia, South Africa. Emerging infectious diseases. 2014 Jul:20(7):1250-1. doi: 10.3201/eid2007.131765. Epub
[PubMed PMID: 24963796]
[45]
Anwar S, Glaser A, Acharya S, Yousaf F. Candida auris-an impending threat: A case report from home. American journal of infection control. 2020 Nov:48(11):1407-1408. doi: 10.1016/j.ajic.2020.01.020. Epub 2020 Mar 12
[PubMed PMID: 32171623]
Level 3 (low-level) evidence
[46]
Horton MV, Johnson CJ, Kernien JF, Patel TD, Lam BC, Cheong JZA, Meudt JJ, Shanmuganayagam D, Kalan LR, Nett JE. Candida auris Forms High-Burden Biofilms in Skin Niche Conditions and on Porcine Skin. mSphere. 2020 Jan 22:5(1):. doi: 10.1128/mSphere.00910-19. Epub 2020 Jan 22
[PubMed PMID: 31969479]
[47]
Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA. Candida auris: a fungus with identity crisis. Pathogens and disease. 2020 Jun 1:78(4):. doi: 10.1093/femspd/ftaa034. Epub
[PubMed PMID: 32643757]
[48]
Yaman G, Akyar I, Can S. Evaluation of the MALDI TOF-MS method for identification of Candida strains isolated from blood cultures. Diagnostic microbiology and infectious disease. 2012 May:73(1):65-7. doi: 10.1016/j.diagmicrobio.2012.01.013. Epub
[PubMed PMID: 22578939]
[49]
Wattal C, Oberoi JK, Goel N, Raveendran R, Khanna S. Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) for rapid identification of micro-organisms in the routine clinical microbiology laboratory. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2017 May:36(5):807-812. doi: 10.1007/s10096-016-2864-9. Epub 2016 Dec 16
[PubMed PMID: 27987046]
[50]
Grenfell RC, da Silva Junior AR, Del Negro GM, Munhoz RB, Gimenes VM, Assis DM, Rockstroh AC, Motta AL, Rossi F, Juliano L, Benard G, de Almeida Júnior JN. Identification of Candida haemulonii Complex Species: Use of ClinProTools(TM) to Overcome Limitations of the Bruker Biotyper(TM), VITEK MS(TM) IVD, and VITEK MS(TM) RUO Databases. Frontiers in microbiology. 2016:7():940. doi: 10.3389/fmicb.2016.00940. Epub 2016 Jun 16
[PubMed PMID: 27379069]
[51]
Wickes BL. Analysis of a Candida auris Outbreak Provides New Insights into an Emerging Pathogen. Journal of clinical microbiology. 2020 Mar 25:58(4):. doi: 10.1128/JCM.02083-19. Epub 2020 Mar 25
[PubMed PMID: 31996439]
[52]
Zhang SX, Carroll KC, Lewis S, Totten M, Mead P, Samuel L, Steed LL, Nolte FS, Thornberg A, Reid JL, Whitfield NN, Babady NE. Multicenter Evaluation of a PCR-Based Digital Microfluidics and Electrochemical Detection System for the Rapid Identification of 15 Fungal Pathogens Directly from Positive Blood Cultures. Journal of clinical microbiology. 2020 Apr 23:58(5):. doi: 10.1128/JCM.02096-19. Epub 2020 Apr 23
[PubMed PMID: 32075904]
[53]
Girard V, Mailler S, Chetry M, Vidal C, Durand G, van Belkum A, Colombo AL, Hagen F, Meis JF, Chowdhary A. Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry. Mycoses. 2016 Aug:59(8):535-8. doi: 10.1111/myc.12519. Epub 2016 Jun 13
[PubMed PMID: 27292939]
[54]
Chaabane F, Graf A, Jequier L, Coste AT. Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris. Frontiers in microbiology. 2019:10():2788. doi: 10.3389/fmicb.2019.02788. Epub 2019 Nov 29
[PubMed PMID: 31849919]
[55]
Fakhim H, Chowdhary A, Prakash A, Vaezi A, Dannaoui E, Meis JF, Badali H. In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris. Antimicrobial agents and chemotherapy. 2017 Nov:61(11):. doi: 10.1128/AAC.01056-17. Epub 2017 Oct 24
[PubMed PMID: 28848002]
[56]
Chowdhary A, Voss A, Meis JF. Multidrug-resistant Candida auris: 'new kid on the block' in hospital-associated infections? The Journal of hospital infection. 2016 Nov:94(3):209-212. doi: 10.1016/j.jhin.2016.08.004. Epub 2016 Aug 15
[PubMed PMID: 27634564]
[57]
Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Flörl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ, ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2012 Dec:18 Suppl 7():19-37. doi: 10.1111/1469-0691.12039. Epub
[PubMed PMID: 23137135]
[58]
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD. Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016 Feb 15:62(4):409-17. doi: 10.1093/cid/civ1194. Epub
[PubMed PMID: 26810419]
Level 1 (high-level) evidence
[59]
Fisher JF, Sobel JD, Kauffman CA, Newman CA. Candida urinary tract infections--treatment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011 May:52 Suppl 6():S457-66. doi: 10.1093/cid/cir112. Epub
[PubMed PMID: 21498839]
[60]
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016 Feb 15:62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16
[PubMed PMID: 26679628]
Level 1 (high-level) evidence
[61]
Mizusawa M, Miller H, Green R, Lee R, Durante M, Perkins R, Hewitt C, Simner PJ, Carroll KC, Hayden RT, Zhang SX. Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories? Journal of clinical microbiology. 2017 Feb:55(2):638-640. doi: 10.1128/JCM.02202-16. Epub 2016 Nov 23
[PubMed PMID: 27881617]
[62]
Osei Sekyere J. Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. MicrobiologyOpen. 2018 Aug:7(4):e00578. doi: 10.1002/mbo3.578. Epub 2018 Jan 18
[PubMed PMID: 29345117]
Level 1 (high-level) evidence
[63]
Morales-López SE, Parra-Giraldo CM, Ceballos-Garzón A, Martínez HP, Rodríguez GJ, Álvarez-Moreno CA, Rodríguez JY. Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia. Emerging infectious diseases. 2017 Jan:23(1):162-164. doi: 10.3201/eid2301.161497. Epub
[PubMed PMID: 27983941]
[64]
Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, Chhina D, Rao R, Eshwara VK, Xess I, Kindo AJ, Umabala P, Savio J, Patel A, Ray U, Mohan S, Iyer R, Chander J, Arora A, Sardana R, Roy I, Appalaraju B, Sharma A, Shetty A, Khanna N, Marak R, Biswas S, Das S, Harish BN, Joshi S, Mendiratta D. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive care medicine. 2015 Feb:41(2):285-95. doi: 10.1007/s00134-014-3603-2. Epub 2014 Dec 16
[PubMed PMID: 25510301]
[65]
Calvo B, Melo AS, Perozo-Mena A, Hernandez M, Francisco EC, Hagen F, Meis JF, Colombo AL. First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia. The Journal of infection. 2016 Oct:73(4):369-74. doi: 10.1016/j.jinf.2016.07.008. Epub 2016 Jul 21
[PubMed PMID: 27452195]
[66]
Abdolrasouli A, Armstrong-James D, Ryan L, Schelenz S. In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris. Mycoses. 2017 Nov:60(11):758-763. doi: 10.1111/myc.12699. Epub 2017 Sep 15
[PubMed PMID: 28872735]
[67]
Cadnum JL, Shaikh AA, Piedrahita CT, Sankar T, Jencson AL, Larkin EL, Ghannoum MA, Donskey CJ. Effectiveness of Disinfectants Against Candida auris and Other Candida Species. Infection control and hospital epidemiology. 2017 Oct:38(10):1240-1243. doi: 10.1017/ice.2017.162. Epub 2017 Aug 10
[PubMed PMID: 28793937]
[68]
Cadnum JL, Shaikh AA, Piedrahita CT, Jencson AL, Larkin EL, Ghannoum MA, Donskey CJ. Relative Resistance of the Emerging Fungal Pathogen Candida auris and Other Candida Species to Killing by Ultraviolet Light. Infection control and hospital epidemiology. 2018 Jan:39(1):94-96. doi: 10.1017/ice.2017.239. Epub 2017 Nov 21
[PubMed PMID: 29157326]
[69]
Moore G, Schelenz S, Borman AM, Johnson EM, Brown CS. Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris. The Journal of hospital infection. 2017 Dec:97(4):371-375. doi: 10.1016/j.jhin.2017.08.019. Epub 2017 Sep 1
[PubMed PMID: 28865738]
[70]
Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, Ryan L, Shackleton J, Trimlett R, Meis JF, Armstrong-James D, Fisher MC. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrobial resistance and infection control. 2016:5():35
[PubMed PMID: 27777756]